Not Yet Recruiting
Zanubrutinib and Acalabrutinib Use and Risk of Atrial Fibrillation in Patients With Chronic B-cell Malignancies
NCT07283965
- Conditions
- BTK Inhibitors, Cardiovascular Diseases, Chronic B-cell Malignancies
- Locations
-
Not specified